Growth factors regulate expression of osteoblast-associated genes

Area of Science:

• Periodontal regenerative medicine
• Biomaterials science
• Cell biology

Background:

• Periodontal regenerative therapies aim to restore bone, cementum, and periodontal ligament (PDL).
• Predictable treatment modalities are crucial for successful tissue reconstruction.
• This study investigates bovine bone protein (BP) extract, containing various bone morphogenetic proteins (BMPs), and its effects on osteoblast differentiation.

Purpose of the Study:

• To determine the effects of a low molecular weight bovine bone protein (BP) extract, alone or combined with platelet-derived growth factor (PDGF) and/or insulin-like growth factor (IGF), on osteoblast differentiation in vitro.
• To evaluate the in vivo bone-forming capacity of BP when incorporated into a polymer matrix.

Main Methods:

• BP was combined with a collagen matrix and a poly (DL-lactide-co-glycolide) polymer (PLG) and implanted in rat skullcaps.
• Histological analysis was performed at 28 days to assess bone formation.
• In vitro studies used MC3T3-E1 cells to assess proliferation (Coulter counter) and gene expression (Northern analysis) in response to BP, PDGF, and IGF.

Main Results:

• In vivo, all sites treated with PLG/BP produced bone, while controls did not.
• In vitro, PDGF increased cell numbers, while BP decreased proliferation.
• BP and IGF promoted osteoblast gene expression (BSP, OPN), with BP and IGF combination showing enhanced OPN expression. PDGF inhibited OPN and OCN expression and could block IGF's effects but not BP's.

Conclusions:

• BP, PDGF, and IGF exhibit distinct effects on osteoblast activity.
• Combining these factors may enhance cellular responses for regenerative applications.
• BP demonstrates in vivo bone-forming capacity and in vitro osteogenic potential.